Nikita K Dave, MD
Hematology, Medical Oncology
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Perelman 4th Floor West
Penn Medicine Provider
About me
- Assistant Professor of Clinical Medicine (Hematology-Oncology)
My education and training
- Residency: Hospital of the University of Pennsylvania
Spoken languages
English
English
Insurance accepted
Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.
- Aetna Advantra Cares D-SNP
- Aetna Advantra Credit Value
- Aetna Advantra Eagle HMO
- Aetna Advantra Eagle POS
- Aetna Advantra Premier Plus PPO
- Aetna Advantra Value
- Aetna Advantra Value Plus
- Aetna APCN Plus (Multi-Tier)
- Aetna Better Health Kids (CHIP) - DH Only
- Aetna Flexible Five
- Aetna Freedom Core
- Aetna Gold
- Aetna HMO
- Aetna Philly Prime
- Aetna POS
- Aetna PPO APCN
- Aetna Premier
- Aetna Premier Plus
- Aetna Savings Plus
- Aetna Signature Administrators
- Aetna Student Health Plan PPO
- Aetna Upfront Advantage
- First Health HMO
- First Health POS
- First Health PPO
- Meritain - Aramark (Other)
- Meritain - Aramark (Pennsylvania Premier Medical Plan)
- Americhealth Caritas of PA VIP - LGH Only
- Amerihealth Caritas (Transplant patients only)
- Amerihealth Caritas of PA - LGH Only
- Centivo EPO
- Cigna Healthcare EPO
- Cigna Healthcare HMO
- Cigna Healthcare POS
- Cigna Healthcare PPO
- Claim Watcher (Homestead/ INDECs) Open Access
- Clover Health Choice
- Clover Health Choice Value PPO
- Clover Health Classic HMO
- Clover Health Value
Locations
Penn Medicine hospital privileges
- Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Dave is a Penn Medicine physician.
Qualifications and experience
- Internal Medicine, 2024
- Lymphoma Committee through the Eastern Cooperative Oncology Group (ECOG)-ACRIN, National
Treatments and conditions
Research
Publications
Dave, N.K., Carvajal, V., Carter, J.S., Cook, M., Thomas, C., Schuster, S.J., Barta, S.K., Svoboda, J., Chong, E.A., Landsburg, D.J., Nasta, S.D. Prolonged Methotrexate, Temozolomide and Rituximab in Secondary Central Nervous System Lymphoma , International Conference of Malignant Lymphoma/Lugano, Swizterland.: 2025
Dave, N.K., Carvajal, V., Carter, J.S., Cook, M., Thomas, C., Schuster, S.J., Barta, S.K., Svoboda, J., Chong, E.A., Landsburg, D.J., Nasta, S.D. Chimeric Antigen Receptor T-Cell Therapy in the Management of Secondary Central Nervous System Lymphomas , Cellicon Valley Meeting, Philadelphia, PA.: 2025
Dave, N.K., Carvajal, P., Watts, A.C., Carter, J.S., Cook, M., Thomas, C., Tsai, D.E., Schuster, S.J., Gerson, J.N., Barta, S.K., Svoboda, J., Chong, E.A., Hwang, W., Landsburg, D.J., Nasta, S.D. Outcomes at a single institution with MTR induction and consolidation in the management of primary CNS lymphoma , Blood Neoplasia , 2(3): 2025,100102.
Ward, R., Dave, N.K., Pai, L.L., Colbourn, R., Banihashemi, A., Nasta, S.D., Babatunde, V. Methotrexate-associated Peripheral Neuropathy on 18 F-FDG PET/CT and MRI Masquerading as Neurolymphomatosis , Clin Nucl Med , 51(2): 2025,e144-e146.
Dave N.K. A Case of Primary CNS Lymphoma Complicated by a Puzzling Peripheral Neuropathy. , Philadelphia Lymphoma Research Foundation Rounds/Philadelphia, PA.: 2025
Dave, N.K., Carvajal, V., Carter, J., Tsai, D.E., Schuster, S.J., Gerson, J., Barta, S.K., Svoboda, J., Chong, E.A., Landsburg, D.J., & Nasta, S.D. Outcomes in Primary CNS Lymphoma: A Single Institution Experience from the Abramson Cancer Center , American Society of Hematology Conference/San Diego, California.: 2024
Brooks, T. R., Zabor, E. C., Bedelu, Y. B., Dave, N., Landsburg, D. J., Nedved, A. N., Wang, Y., Reinert, C., Major, A., Sears-Smith, M., Ghosh, N., Salafian, K., Ayers, E., Miller, J., Grover, N., Peterson, C., Khan, C., Bliven, S. P., Narkhede, M. S., … Hill, B. T. Real-world outcomes with Bispecific T-cell engagers (REALBiTE) for relapsed or refractory large B-cell lymphoma: A multi-center, retrospective cohort study , American Society of Hematology Conference, San Diego, California.: 2024
Dave, N.K., Morrissette, J.J., Schuster, S.J., Nasta, S.D., Gerson, J.N., Barta, S.K., Svoboda, J., Chong, E.A., Lim, M.S., Landsburg, D.J. Clinical Laboratory mutation Analysis Performed on Tumor Biopsies from patients with First Relapsed/Refractory Aggressive B Cell Lymphoma Treated with Curative-Intent Immunochemotherapy , American Society of Hematology Conference/New Orleans, Louisiana, USA.: 2022
Dave N.K. Response to Neoadjuvant Treatment for Esophageal Cancer May Predict Increased Incidence of Brain Metastases Compared to Other Metastasis Sites , Memorial Sloan Kettering Cancer Center/New York City, NY.: 2017